The antibiotic resistance pattern of salmonella is ever changing over time. The present study is a retrospective analysis of rate of isolation of Salmonella Typhi and Paratyphi and their antibiotic resistance pattern over 6 years period in an urban hospital of Dhaka city. Blood culture submitted in BIRDEM hospital from 2004-2009 were analyzed. Isolated Salmonella sp were identified and antimicrobial susceptibility testing was carried out by a standard disc diffusion method.
Introduction
Typhoid fever is an important public-health problem in Bangladesh. Salmonella enterica serovar Typhi and Paratyphi are common etiological agents of typhoid. With the emergence of resistance to ampicillin, chloramphenicol and cotrimoxazole, first choice of empiric treatment of typhoid fever has changed to ciprofloxacin and ceftriaxone.
1-3 But there are reports of appearance of ciprofloxacin resistant salmonella from Bangladesh and other countries.
4, 5 Resistance to ceftriaxone has also been reported from Bangladesh in 1999. 6 Recently, there is emergence of salmonella strains that are ciprofloxacin sensitive but nalidixic acid resistant. Treatment of these strains with the usual dose of ciprofloxacin resulted in poor clinical outcome as well as treatment failure.
7-10 All these reports suggest that fluoroquinolones should no longer be used as the first-line therapy in populations where nalidixic acid resistance is common among isolates of S. Typhi. Moreover, recent studies indicate that the proportion of S. Paratyphi is increasing over the years in the subcontinent.
11,12 Therefore, it is important to know the species of Salmonella that are prevalent in a country and the antibiotic susceptibility pattern of that prevalent Salmonella sp. 
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Materials and Methods
A retrospective analysis of Salmonella Typhi and Paratyphi isolated from patients attending BIRDEM hospital during 2004 to 2009 was carried out. BIRDEM hospital is a 600 bed tertiary care referral hospital in Dhaka city. All the isolates were identified by colony morphology, standard biochemical reactions and by agglutination with specific antiserum. 13 The isolates were tested for susceptibility to ciprofloxacin 5µg, nalidixic acid 30 µg, chloramphenicol 30 µg, cotrimoxazole 25 µg, ampicillin 10 µg, cefepime30 µg and ceftriaxone 30 µg by a disk diffusion technique as recommended by the NCCLS guideline.
14 All disks were obtained from Oxoid Ltd, Basingstoke, Hampshire, UK. Potency of the disks and antibiotics were standardized using the reference strain E. coli ATCC 25922.
Results
A total of 385 Salmonella were isolated from blood cultures over the period of 6 years. S. Typhi was the predominant serotype followed by Salmonella Paratyphi A ( Table-1 
Discussion
Typhoid fever is endemic in Bangladesh. 16 The present study was conducted as a part of the continuous surveillance about the prevalence of Salmonella sp and their antimicrobial susceptibility pattern which was very important to institute appropriate antimicrobial therapy. The study revealed that there was gradual emergence of S. Paratyphi A during the period as a cause of typhoid fever. Among the total isolated salmonella, S. Typhi was about 79% where as S. 
11,12
The number of S. Typhi simultaneously resistant to all three first line drugs namely ampicillin, chloramphenicol and cotrimoxazole declined towards 2007 and continued through 2009. It might be due to the loss of unstable resistant gene resulting from removal of selection pressure of these antibiotics.
15
Re-emergence of the sensitivity to these drugs were also reflected from the individual upward trend of sensitivity pattern through recent years. S. paratyphi A showed moderate to high sensitivity to those drugs through out the last six years and there was only one multi drug resistant isolate out of total 81 isolates.
With the emergence of salmonella strains resistant to the first line drugs, quinolones and third generation cephalosporin (ceftriaxone and cefixime) are extensively being used in the treatment of typhoid fever during last decade. But, no ceftriaxone resistant isolate was found during the six years study period. However, 7-28% S. Typhi and S. Paratyphi A were resistant to cefixime.
Ciprofloxacin is being used as the first choice of empiric treatment of typhoid in Bangladesh for last several years. But the current study revealed that about 80-100% of S. typhi and S. Paratyphi A were resistant to nalidixic acid. The treatment of typhoid due to nalidixic acid resistant Salmonella sp with ciprofloxacin is less effective as there were reports of treatment failures from Bangladesh and other countries.
7-10 It was due to higher minimum inhibitory concentration of ciprofloxacin of these isolates. Nalidixic acid resistant S. Typhi had been reported to have higher minimum inhibitory concentration of ciprofloxacin compared to susceptible strains. 10 So, it has been recommended that quinolones should not be used as the first-line therapy in populations like Bangladesh where nalidixic acid resistance is common among isolates of salmonella. However, gatifloxacin may be used as alternative as because it has different mechanism to develop resistance than that of ciprofloxacin.
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Thus, our study indicates that the isolation of S. Paratyphi A is increasing over the years and the resistance to antibiotics among S. Typhi and S. Paratyphi is rising in our country. On the other hand, there has been a re-emergence of sensitivity to first line anti-salmonella drugs like ampicillin, chloramphenicol and cotrimoxazole. Nalidixic acid resistant organisms should be screened routinely to detect organisms with reduced susceptibility to ciprofloxacin to avoid treatment failure with quinolone therapy.
